These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Impact of arginine therapy on mitochondrial function in children with sickle cell disease during vaso-occlusive pain. Morris CR; Brown LAS; Reynolds M; Dampier CD; Lane PA; Watt A; Kumari P; Harris F; Manoranjithan S; Mendis RD; Figueroa J; Shiva S Blood; 2020 Sep; 136(12):1402-1406. PubMed ID: 32384147 [TBL] [Abstract][Full Text] [Related]
6. A randomized controlled trial comparing two vaso-occlusive episode (VOE) protocols in sickle cell disease (SCD). Tanabe P; Silva S; Bosworth HB; Crawford R; Paice JA; Richardson LD; Miller CN; Glassberg J Am J Hematol; 2018 Feb; 93(2):159-168. PubMed ID: 29047145 [TBL] [Abstract][Full Text] [Related]
7. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
8. IMPROVE trial: a randomized controlled trial of patient-controlled analgesia for sickle cell painful episodes: rationale, design challenges, initial experience, and recommendations for future studies. Dampier CD; Smith WR; Wager CG; Kim HY; Bell MC; Miller ST; Weiner DL; Minniti CP; Krishnamurti L; Ataga KI; Eckman JR; Hsu LL; McClish D; McKinlay SM; Molokie R; Osunkwo I; Smith-Whitley K; Telen MJ; Clin Trials; 2013 Apr; 10(2):319-31. PubMed ID: 23539110 [TBL] [Abstract][Full Text] [Related]
9. Low dose ketamine versus morphine for acute severe vaso occlusive pain in children: a randomized controlled trial. Lubega FA; DeSilva MS; Munube D; Nkwine R; Tumukunde J; Agaba PK; Nabukenya MT; Bulamba F; Luggya TS Scand J Pain; 2018 Jan; 18(1):19-27. PubMed ID: 29794277 [TBL] [Abstract][Full Text] [Related]
10. Ketamine use for management of vaso-occlusive pain in pediatric sickle cell disease. Harris EM; Vilk E; Donado C; Williams A; Heeney MM; Solodiuk J; Greco C; Archer NM Pediatr Blood Cancer; 2023 May; 70(5):e30254. PubMed ID: 36861789 [TBL] [Abstract][Full Text] [Related]
11. Intravenous magnesium for pediatric sickle cell vaso-occlusive crisis: methodological issues of a randomized controlled trial. Badaki-Makun O; Scott JP; Panepinto JA; Casper TC; Hillery CA; Dean JM; Brousseau DC; Pediatr Blood Cancer; 2014 Jun; 61(6):1049-54. PubMed ID: 24443249 [TBL] [Abstract][Full Text] [Related]
12. A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodes. Morris CR; Kuypers FA; Lavrisha L; Ansari M; Sweeters N; Stewart M; Gildengorin G; Neumayr L; Vichinsky EP Haematologica; 2013 Sep; 98(9):1375-82. PubMed ID: 23645695 [TBL] [Abstract][Full Text] [Related]
13. Normal saline bolus use in pediatric emergency departments is associated with poorer pain control in children with sickle cell anemia and vaso-occlusive pain. Carden MA; Brousseau DC; Ahmad FA; Bennett J; Bhatt S; Bogie A; Brown K; Casper TC; Chapman LL; Chumpitazi CE; Cohen D; Dampier C; Ellison AM; Grasemann H; Hickey RW; Hsu LL; Leibovich S; Powell E; Richards R; Sarnaik S; Weiner DL; Morris CR; Am J Hematol; 2019 Jun; 94(6):689-696. PubMed ID: 30916794 [TBL] [Abstract][Full Text] [Related]
14. Intranasal fentanyl versus intravenous morphine in the emergency department treatment of severe painful sickle cell crises in children: study protocol for a randomised controlled trial. Barrett MJ; Cronin J; Murphy A; McCoy S; Hayden J; an Fhailí S; Grant T; Wakai A; McMahon C; Walsh S; O'Sullivan R Trials; 2012 May; 13():74. PubMed ID: 22647439 [TBL] [Abstract][Full Text] [Related]
15. Improving the Management of Vaso-Occlusive Episodes in the Pediatric Emergency Department. Kavanagh PL; Sprinz PG; Wolfgang TL; Killius K; Champigny M; Sobota A; Dorfman D; Barry K; Miner R; Moses JM Pediatrics; 2015 Oct; 136(4):e1016-25. PubMed ID: 26391933 [TBL] [Abstract][Full Text] [Related]
16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
17. Ticagrelor versus placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: Rationale and design of a randomized, double-blind, parallel-group, multicenter phase 3 study (HESTIA3). Heeney MM; Abboud MR; Amilon C; Andersson M; Githanga J; Inusa B; Kanter J; Leonsson-Zachrisson M; Michelson AD; Berggren AR; Contemp Clin Trials; 2019 Oct; 85():105835. PubMed ID: 31446143 [TBL] [Abstract][Full Text] [Related]
18. Addressing challenges of clinical trials in acute pain: The Pain Management of Vaso-occlusive Crisis in Children and Young Adults with Sickle Cell Disease Study. Nottage KA; Hankins JS; Faughnan LG; James DM; Richardson J; Christensen R; Kang G; Smeltzer M; Cancio MI; Wang WC; Anghelescu DL Clin Trials; 2016 Aug; 13(4):409-16. PubMed ID: 27000103 [TBL] [Abstract][Full Text] [Related]
19. Study protocol for a randomized, blinded, controlled trial of ketamine for acute painful crisis of sickle cell disease. Alshahrani MS; Asonto LP; El Tahan MM; Al Sulaibikh AH; Al Faraj SZ; Al Mulhim AA; Al Abbad MF; Al Nahhash SA; Aldarweesh MN; Mahmoud AM; Almaghraby N; Al Jumaan MA; Al Junaid TO; Al Hawaj FM; AlKenany S; ElSayed OF; Abdelwahab HM; Moussa MM; Alossaimi BK; Alotaibi SK; AlMutairi TM; AlSulaiman DA; Al Shahrani SD; Alfaraj D; Alhazzani W Trials; 2019 May; 20(1):286. PubMed ID: 31133061 [TBL] [Abstract][Full Text] [Related]
20. Hydroxyurea Optimization through Precision Study (HOPS): study protocol for a randomized, multicenter trial in children with sickle cell anemia. Meier ER; Creary SE; Heeney MM; Dong M; Appiah-Kubi AO; Nelson SC; Niss O; Piccone C; Quarmyne MO; Quinn CT; Saving KL; Scott JP; Talati R; Latham TS; Pfeiffer A; Shook LM; Vinks AA; Lane A; McGann PT Trials; 2020 Nov; 21(1):983. PubMed ID: 33246482 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]